Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Sigrid Therapeutics Logo
Sigrid Therapeutics Growth Score
75
CB Rank
45257
Heat Score
43
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Founded
obfuscation
PrivateFunding Round Stockholm, Stockholms Lan, Sweden11-50 www.sigridthx.com/
Biotechnology
Medical Device
Overview

Sigrid Therapeutics
Total Funding
obfuscation
Growth Score
75
Heat Score
43

Total Funding
obfuscation
obfuscation
Funding Round raised
obfuscation
Growth Score75
-17 pts
in past quarter
Heat Score 43
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Sigrid Therapeutics

CB Rank
45257
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Founded
obfuscation
PrivateFunding Round Stockholm, Stockholms Lan, Sweden11-50 www.sigridthx.com/
Biotechnology
Medical Device

Funding Rounds

Funding Round
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Sigrid Therapeutics AB
Operating Status Active
Company Type For Profit
Founders  Sana Alajmovic, Tore Bengtsson
About the Company
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Phone Number +46723893396
Predictions & Insights

Growth Insight

See this Growth Insight
Sigrid Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

SiPore21®
An ingested medical device designed to lower blood sugar levels in prediabetics and newly diagnosed type 2 diabetics.
SiPore®
A platform technology for developing treatments for metabolic diseases, utilizing engineered silica particles that work in the gut without being absorbed.

Research & Development

Sigrid Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - Sigrid Therapeutics Logo
Funding Round - Sigrid Therapeutics
—
obfuscation
— Funding Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Photo of Mattias Ankarberg
Mattias Ankarberg
—
Venture Round - Sigrid Therapeutics Logo
Venture Round - Sigrid Therapeutics
—
Photo of Mattias Ankarberg
Mattias Ankarberg
—
Venture Round - Sigrid Therapeutics Logo
Venture Round - Sigrid Therapeutics
—
Photo of Mattias Ankarberg
Mattias Ankarberg
—
Venture Round - Sigrid Therapeutics Logo
Venture Round - Sigrid Therapeutics
—
Photo of Mattias Ankarberg
Mattias Ankarberg
—
Venture Round - Sigrid Therapeutics Logo
Venture Round - Sigrid Therapeutics
—
Photo of Mattias Ankarberg
Mattias Ankarberg
—
Venture Round - Sigrid Therapeutics Logo
Venture Round - Sigrid Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 1 Contacts 10

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jan 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

669
-50.41%
 in past month

IT Spend

$104.4KThis year, Sigrid Therapeutics is projected to spend $104.4K on IT, according to Aberdeen.

Active Website Tech Count

3Sigrid Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m and  SiteGround CAPTCHA.

Total IP

27The intellectual property of Sigrid Therapeutics includes 11 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Sigrid Therapeutics has registered 16 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Sigrid Therapeutics's headquarters? Sigrid Therapeutics is located in Stockholm, Stockholms Lan, Sweden.Who invested in Sigrid Therapeutics? Sigrid Therapeutics has 9 investors including Mattias Ankarberg and  Joyance Partners.When was the last funding round for Sigrid Therapeutics? Sigrid Therapeutics closed its last funding round on
obfuscation
from a Undisclosed round.Who are Sigrid Therapeutics's competitors? Alternatives and possible competitors to Sigrid Therapeutics may include Eli Lilly, Sanofi, and  Bayer.How much funding has Sigrid Therapeutics raised to date? Sigrid Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|